Epilepsy, a chronic neurological disorder, is characterized by recurrent seizures affecting approximately 50 million people globally. Despite the progress in therapeutic strategies, about one-third of patients continue to experience uncontrolled seizures. This article aims to shed light on the recent advancements in epilepsy management, offering a comprehensive update for healthcare professionals.
Newer AEDs offer improved safety profiles, fewer drug interactions, and better tolerability. Drugs such as Brivaracetam, Perampanel, and Lacosamide have shown promising results in controlling both focal and generalized seizures. These drugs work by modulating synaptic transmission, thereby reducing the frequency and severity of seizures.
Neuromodulation therapies such as Vagus Nerve Stimulation (VNS), Deep Brain Stimulation (DBS), and Responsive Neurostimulation (RNS) have emerged as effective treatment options for drug-resistant epilepsy. These therapies work by altering neuronal activity, thereby reducing seizure frequency. RNS, in particular, has shown potential in detecting abnormal electrical activity and delivering corrective stimulation.
Genetic testing has greatly improved our understanding of epilepsy's etiology, leading to the development of precision medicine. Identifying specific genetic mutations allows for targeted therapy, improving treatment outcomes. For instance, Stiripentol has been approved for Dravet syndrome, a severe form of epilepsy caused by SCN1A mutations.
The COVID-19 pandemic has accelerated the adoption of telemedicine in epilepsy care. Telemedicine allows for remote patient monitoring, improving treatment adherence and seizure control. Additionally, digital tools such as seizure detection apps and wearable devices provide real-time data, facilitating personalized care.
In conclusion, the field of epilepsy management has seen significant advancements. The introduction of new AEDs, neuromodulation therapies, precision medicine, and digital tools have improved patient outcomes. As healthcare professionals, staying updated with these advancements is crucial to provide optimal care for patients with epilepsy.
1.
Combo Therapy Boosts Early CML Response but Not Long Term
2.
PNH With Extravascular Hemolysis Approves Factor D Inhibitor.
3.
In a long-term comparison with adjuvant RT, salvage radiotherapy after prostateectomy is the most successful treatment.
4.
AI Breath Test IDs Cancers; More Grief for Prior Auth; Imatinib Discoverer Resigns
5.
Classifying childhood brain cancers by immune response may improve diagnostics and treatments
1.
Precision Oncology: Integrating Genomics and Data to Shape Cancer Care’s Future
2.
Decoding Hamartomas: Understanding Their Causes and Symptoms
3.
Understanding the Silent Threat: Unveiling Prostate Cancer Symptoms
4.
Battling Blood Cancers: Advances in HIV-Related Hematologic Malignancies in the ART Era
5.
Breaking Barriers: Innovative Approaches in Brain Tumor Treatment
1.
Asian Symposium on Advancement in Hematology and Oncology
2.
Asian Symposium on Advancement in Hematology and Oncology
3.
Asian Symposium on Advancement in Hematology and Oncology
4.
International Cancer Conference
5.
Asian Symposium on Advancement in Hematology and Oncology
1.
Effect of Pablociclib in Endocrine Resistant Patients - A Panel Discussion
2.
Recent Data Analysis for First-Line Treatment of ALK+ NSCLC: A Final Discussion
3.
Efficient Management of First line ALK-rearranged NSCLC
4.
Updates on Standard V/S High Risk Myeloma Treatment- The Next Part
5.
Pazopanib: A Game-Changer in Managing Advanced Renal Cell Carcinoma
© Copyright 2026 Hidoc Dr. Inc.
Terms & Conditions - LLP | Inc. | Privacy Policy - LLP | Inc. | Account Deactivation